Loading clinical trials...
Loading clinical trials...
This prospective, randomized study,control study aims to compare the analgesic effect,opioids consumption,quality of recovery,length of hospital stay and incidence of chronic pain,et al. between single-injection QLB(quadratus lumborum block)+ intravenous patient-controlled analgesia (IPCA) and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing laparoscopic renal surgeries.
Age
17 - 80 years
Sex
ALL
Healthy Volunteers
No
Xulei CUI
Beijing, Beijing Municipality, China
Start Date
August 1, 2016
Primary Completion Date
November 1, 2018
Completion Date
December 1, 2018
Last Updated
May 20, 2019
30
ACTUAL participants
single-injection QLB(quadratus lumborum block)
PROCEDURE
Philip CX50 Ultrasound Scanner
DEVICE
PAJUNK StimuLong
DEVICE
single dose ropivacaine
DRUG
Morphine given as IPCA(intravenous patient controlled analgesia)
DRUG
Lead Sponsor
Cui Xulei
NCT07327463
NCT07432711
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions